Skip to main content

Table 3 I.p. application of trAb anti-Her2/neu and side effects

From: Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis

Pat.

TrAb anti Her2/neu therapy (μg i.p./day)

Cumulative dose

Side effects

 

μg

Day

μg

Day

μg

day

(μg)

 

D

10

1

40

4

80

8

130

Fever (1)

E

10

1

40

6

80

8

130

Fever (1); abdominal pain (2)

  1. Individual schedule of trAb therapy and side effects according to the National Cancer Institute (NCI) common toxicity criteria.